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Abstract
The chest X-ray lung cancer screening program of Mayo Lung Project (MLP) yielded mixed results of improved
lung case survival but no improvement in lung cancer mortality. This paper analyzes the smoking patterns of study
participants in order to examine possible behavioral ramifications of periodic lung cancer screening. Using a
longitudinal difference-of-difference model, we compared the smoking behavior, in terms of current smoker status
among all subjects and the intensity of smoking among those continuing smokers, between those who received
periodic lung cancer screening and those who received usual-care. In both arms of this lung cancer screening trial,
there was a sizable decline in cigarette smoking one year after participants received baseline prevalence screening.
There was no significant difference in current smoker status between the intervention group receiving periodic X-
ray screening and the control group receiving usual care. While we detect that the continuing smokers in the
intervention group smoked more than their counterparts in the control group, the magnitude of the difference is
not sufficient to explain a substantial difference in lung cancer incidence between the two groups. Our study
shows that periodic lung screening in MLP did not decrease smoking behavior beyond the observed decline
following the initial prevalence screening conducted at baseline for both the intervention and control groups. Our
results also indicate, paradoxically, that participants assigned to the intervention group smoked more cigarettes per
day on average than those in the control group. Lung cancer screening programs need additional cessation
components to sustain the abstinence effect typically observed following initial lung screening.
Introduction
The Mayo Lung Project (MLP) was a clinical trial con-
ducted between 1971 and 1983. It involved random
assignment of male smokers to either a periodic (every
4-6 months) chest X-ray lung cancer screening program
versus a usual care program that included the “treat-
ment as usual” (TAU) recommendation to be screened
yearly. The two trial arms then went through a preva-
lence screening, where 9,211 subjects were diagnosed as
cancer-free and thus eligible for staying in the study.
Those in the intervention arm then received periodic
chest roentgenograms and three-day “pooled” sputum
cytology studies thrice a year while lung-health ques-
tionnaires were delivered to both arms of the trial. The
MLP results were mixed inasmuch as participants in the
periodic screening program demonstrated longer case
survival but worse lung cancer mortality as compared
with those in the usual care program [1-3].
Surprisingly, no attention has been paid to the smok-
ing behavior of MLP participants, even though smoking
status has been shown to be the most important predic-
tor of lung cancer incidence and survival. This study
examines the interaction between periodic lung cancer
screening and smoking behavior reported in the MLP in
order to better understand the behavioral contributors
to observed outcomes.
It is well established that smoking cessation could sig-
nificantly reduce smokers’ lung cancer mortality [4].
Further, we know that if individuals are alerted to avoid-
able fatal risks, they often take steps to reduce that risk
[5]. Therefore, it is reasonable to infer that undergoing
periodic lung cancer screening, which serves as a con-
stant reminder of the deadly outcome of cigarette smok-
ing, could stimulate smoking cessation among current
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diseases has suggested that episodic medical occasions
that heighten the patient’sa w a r e n e s so fd i s e a s er i s k ,
often called “the teachable moment”[6-8], can signifi-
cantly motivate the patient to reduce or abandon the risk
behavior[9-13]. For example, smokers who went through
heart-related surgeries maintained an abstinence rate of
48% at 5-year follow-up, a level that no known interven-
tions have achieved [10]. However, other than a single-
arm study that showed an increase in smoking cessation
efforts after people attended lung cancer screening [6],
there has been insufficient documented evidence of lung
cancer screening’s causal impact on smoking cessation
among those screened. Now that the policy debate over
mandating a periodic CT screening of smokers has
attracted widespread academic interest and media atten-
tion [14,15], the question of whether the screening inter-
vention could lead to smoking cessation has become
timely. This paper examines two aspects of smoking
behavior observed during the MLP: the current smoking
status (whether one smoked any cigarette in a given year)
and the amount of cigarettes smoked per day.
Method
The MLP tracked smoking behavior at baseline and then
annually for six years [16]. We adopt a difference-of-dif-
ference longitudinal logistic model [17] to examine the
screening intervention’s effect on current smoker status
(defined as smoking at least one cigarette vs. not smoking
a single cigarette per day in the past year) and smoking
intensity (defined as daily number of cigarettes con-
sumed). We set the time period and intervention assign-
ment as fixed effects and each participant as a random
effect to examine the difference-of-difference in smoking
behavior change over time across the two trial arms.
Results
We first compared smoking behavior at baseline and the
first-year follow-up, and in both trial arms we found a
dramatic increase in smoking abstinence and a large
decrease in number of cigarettes smoked per day. Of
the 9,211 smokers enrolled in MLP, 690 quit smoking
in the screening intervention group and 692 quit in the
control group. On average, participants in the screening
intervention group cut down on their daily smoking by
5.69 cigarettes (p < 0.001) while the control group
decreased by 5.71 cigarettes (p < .001). In all, approxi-
mately 42% of participants in both groups reported a
decrease in the number of cigarettes consumed. In the
sixth year since MLP’s baseline screening, 53.6% of the
participants in the intervention arm and 57.0% of parti-
cipants in the control arm reported a reduction of the
number of cigarettes smoked per day compared to their
baseline smoking intensity.
Results from the mixed model indicated that the
screening intervention had no significant impact on cur-
rent smoker status when compared to the control
group, and that smoking intensity declined less in the
intervention group than in the control group (Table 1).
Overall, smoking intensity in the intervention group was
observed to be higher by 1.90 cigarettes per day (p <
0.001). Participant age negatively predicted current smo-
ker status (O.R. = 0.95; p < 0.001) while each additional
year in age was associated with 0.51 fewer cigarettes
smoked per day (p < 0.001). Years of smoking positively
predicted current smoker status (O.R. = 1.03; p < 0.001)
with each additional year of smoking associated with
0.15 more cigarette smoked per day (p < 0.001). Being
White negatively predicts current smoker status (O.R. =
0.75; p < 0.001) and is associated with 0.82 fewer cigar-
ettes smoked per day (p < 0.05).
Discussion
Among the many studies that have analyzed the MLP
data, this study is the first to look at the smoking beha-
vior of the participants. The finding here that smokers
in the intervention arm smoked more than those in the
control group does not necessarily constitute an argu-
ment against lung cancer screening. First, it is not plau-
sible that a difference of one or two cigarettes a day
could lead to significantly different health conditions
among continuing smokers, and in our study no
between-group differences were noted in rates of absti-
nence. Secondly, we did observe a sizable decline in
smoking among all participants after the prevalence
lung cancer screening was administered to both groups
at baseline. Since it was then that some prevention
counseling was given to participants, given what we
know about the strong proven effect of counseling on
smoking cessation [18], this large initial decline in
smoking could be viewed as evidence supporting the
Table 1 Difference-of-difference mixed models comparing
the smoker status (1 = smoking 0 = abstinence) and
smoking intensity (daily consumption of cigarettes)
between the screening intervention group and the
control group in Mayo Lung Project of Chest X-rays
Current Smoker Status Smoking Intensity
abstinence = 0,
smoker = 1
(Odds Ratios)
Linear regression
coefficients
Age 0.95*** -0.51***
Years of Smoking 1.03*** 0.15***
Had cancer Before 1.03 -0.24
Race (White) 0.75*** -0.82*
Screening
intervention
1.03 1.90***
* p < .05, *** p < .001.
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pants receiving frequent screening reported significantly
higher rates of cigarettes smoked per day might also
indicate a paradoxical response to screening. In any
case, periodic lung cancer screening appears not to
improve long-term abstinence as compared with one-
shot screening, a result contrary to what many would
have expected but which is consistent with the results
reported by Cox et al [5].
From the viewpoint of “risk compensation” (whereby
people adjust their risk behavior to adapt for the changed
risk), it is not surprising to see that smokers in the inter-
vention group smoked more cigarettes per day than
those in the control group. The human phenomena of
behaviorally offsetting exogenous risk modification has
been noted and interpreted ind i f f e r e n td i sciplines like
economics, psychology and risk analysis [19-22], includ-
ing studies of smoking behavior [23,24]. Wilde [25] pro-
posed a theory of “risk homeostasis” that individuals seek
a stable target level of risk to bear and therefore will
adjust behavior in response to exogenous changes in risk
to maintain that target. Wilde [26] argues that interven-
tions that have a direct influence on accident cost could
successfully alter the target risk level, like countermea-
sures that increase the benefits associated with accident-
free driving and the costs associated with accident invol-
vement. In our context, going through a lung screening
program with repeated negative results may conceptually
reduce the expected risk of dying from smoking, both by
lowering the perceived probability of having lung cancer
and by increasing the expected expediency of treatment.
Therefore, the expected cost of smoking for participants
in the intervention group is lower than for participants in
the control group. In other words, the perceived fatal risk
of smoking could actually be lowered by repeated nega-
tive screening results, and thus lead to more cigarettes
smoked per day. Thus, it might be worthwhile to remind
smokers undergoing lung cancer screenings that repeated
negative results do not imply one’s immunity from
tobacco-induced lung cancer. Finally, the fact that peri-
odic lung cancer screening neither increased smoking
abstinence nor decreased smoking intensity also suggests
a need to add smoking cessation interventions into
screening programs in order to capitalize on the “teach-
able moment” in later screenings, as Taylor et al [6] did
in their study. It takes very little time to refer a screened
smoker to existent hotline counseling services like the
proven tool of Quitline [27,28].
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